News

Filter

Current filters:

Fablyn

Ligand in deal with Chiva for global rights to Fablyn

12-10-2011

In a second deal with the company, Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a global licensing…

Anti-Arthritics/RheumaticsChiva PharmaFablynLicensingLigand PharmaceuticalsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top